Clinical and echocardiographic features of hypertrophic cardiomyopathy in the elderly

J F Lewis1

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, University of Florida College of Medicine, 1600 Archer Road, P.O. Box 100277, Room M437, Gainesville, FL 32610-0277, USA.

Insights

Hypertrophic cardiomyopathy presents differently based on age. This review highlights key differences in elderly patients regarding presentation, diagnosis, and management of this genetic heart condition.

Area of Science:

  • Cardiology
  • Genetics
  • Geriatrics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart condition with varied clinical and morphological features.
  • Historically, research focused on younger individuals, but recent studies emphasize age-related manifestations.

Purpose of the Study:

  • To review and synthesize current literature on age-related differences in hypertrophic cardiomyopathy.
  • To provide insights into the clinical presentation, echocardiographic findings, prognosis, and management of HCM in elderly patients.

Main Methods:

  • Literature review of studies published within the last decade.
  • Focus on research comparing hypertrophic cardiomyopathy in younger versus elderly populations.

Main Results:

  • Elderly patients with hypertrophic cardiomyopathy often present with distinct clinical symptoms and echocardiographic findings compared to younger individuals.
  • Age influences the prognosis and management strategies for hypertrophic cardiomyopathy.

Conclusions:

  • Understanding age-specific differences is crucial for accurate diagnosis and effective management of hypertrophic cardiomyopathy.
  • Further research is needed to optimize treatment approaches for elderly patients with this cardiac disease.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...